- Age: 18+
Brand: Revuele
Line: daily sun barrier
Product Type: face cream
Product Properties: moisturizing, nourishment, repair, sun protection
Protection Level: spf 50
Ingredients: allantoin, glycerin, hyaluronic acid, zinc oxide
When To Use: universal
Gender: for women
Classification: mass-market
Skin Type: all types
Country: Bulgaria
Made in: Bulgaria -
The Revuele Daily SPF50 Barrier Face Cream offers reliable skin protection in urban environments and during extended sun exposure. This cream forms a barrier against the harmful effects of ultraviolet rays while simultaneously providing hydration and skin restoration. The Revuele brand ensures dependable protection from harmful radiation with its high SPF50, allowing you to enjoy the outdoors with peace of mind.
Features of Revuele Daily Sun Barrier Face Moisturizer:
– Contains glycerin, which moisturizes the skin and retains moisture for an extended period;
– Includes zinc oxide to create a physical barrier against UVA and UVB rays;
– Enriched with hydrolyzed guar extract for additional nourishment and skin restoration;
– Contains allantoin to soothe irritations and promote quick healing;
– Formulated with hyaluronic acid to enhance skin elasticity and provide deep hydration;
– Protects the epidermis from photoaging and pigmentation with high-protection filters;
– Free from parabens and harsh substances, making it safe for sensitive skin;
– SLS/SLES-free formula for gentle care;
– Quickly absorbed without leaving a greasy shine. -
Use as the final step in your morning skincare routine. Apply to clean skin on the face and neck. It is recommended to reapply throughout the day. Reducing the amount applied significantly decreases the level of protection. Can be used without a moisturizer. Warning: Individual intolerance to any of the ingredients is possible. Avoid contact with eyes. In case of contact with eyes, rinse immediately with water. Midday sun and excessive sun exposure pose serious health risks, even when using sunscreen products.
Reviews
There are no reviews yet.